Cargando…
Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma
BACKGROUND: Current imaging criteria for categorising disease response in metastatic renal cell carcinoma (mRCC) correlate poorly with overall survival (OS) in patients on anti-angiogenic therapies. We prospectively assess diffusion-weighted and multiphase contrast-enhanced (MCE) MR imaging (MRI) as...
Autores principales: | Bharwani, N, Miquel, M E, Powles, T, Dilks, P, Shawyer, A, Sahdev, A, Wilson, P D, Chowdhury, S, Berney, D M, Rockall, A G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915138/ https://www.ncbi.nlm.nih.gov/pubmed/24366299 http://dx.doi.org/10.1038/bjc.2013.790 |
Ejemplares similares
-
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
por: Powles, T., et al.
Publicado: (2011) -
Sunitinib and other targeted therapies for renal cell carcinoma
por: Powles, T, et al.
Publicado: (2011) -
Contrasting effects of sunitinib within in vivo models of metastasis
por: Welti, Jonathan C., et al.
Publicado: (2012) -
Multiphase Microfluidics The Diffuse Interface Model
por: Mauri, Roberto
Publicado: (2012) -
Diffusion-weighted imaging and dynamic contrast-enhanced MRI in assessing response and recurrent disease in gynaecological malignancies
por: Hameeduddin, Ayshea, et al.
Publicado: (2015)